LncRNA-SChLAP1在结直肠癌组织中高表达的预后评估意义

doi:10.11904/j.issn.1002-3070.2020.05.007

实用肿瘤学杂志 ›› 2020, Vol. 34 ›› Issue (5): 425-429.doi: 10.11904/j.issn.1002-3070.2020.05.007

LncRNA-SChLAP1在结直肠癌组织中高表达的预后评估意义

孙小艳¹, 张晓艳²

1.丹东市第一医院消化内科(丹东 118001);
2.沈阳市第五人民医院;沈阳肿瘤医院病理科

收稿日期:2020-03-21 出版日期:2020-10-28 发布日期:2020-11-02
通讯作者: 张晓艳,E-mail:469169488@qq.com
作者简介:孙小艳,女,(1981-),硕士,主治医师,从事消化道肿瘤分子及临床的研究。

Prognostic significance of lncRNA-SChLAP1 high-expression in colorectal cancer

SUN Xiaoyan¹, ZHANG Xiaoyan²

1. Department of Gastroenterology,Dandong First Hospital,Dandong 118001,China;
2. Department of Pathology,Fifth People′s Hospital of Shenyang City & Shenyang Tumor Hospital

Received:2020-03-21 Online:2020-10-28 Published:2020-11-02

摘要/Abstract

摘要： 目的探讨长链非编码RNA-SChLAP1过表达对结直肠癌(CRC)预后的影响。方法选取符合严格随访标准的156例CRC患者和 43例癌旁结直肠组织进行qRT-PCR检测,评估SChLAP1表达与CRC临床病理特征和总生存期(OS)、无病生存期(DFS)的关系,以及影响CRC患者OS和DFS的风险因素。结果 CRC中SChLAP1水平明显高于癌旁结直肠组织,差异有统计学意义(P＜ 0.01)。SChLAP1高表达与CRC的分化和分期有关,也与DFS和OS有关(P＜ 0.01)。Cox比例风险回归模型发现SChLAP1表达是CRC患者OS和DFS下降的独立风险因素。结论 SChLAP1在CRC进展中起着重要作用,SChLAP1 可能作为独立的生物标志物用于CRC的预后评估。

关键词: lnc-RNA, SChLAP1, 结直肠癌, 预后, 生存分析

Abstract: Objective To investigate the effect of long-chain non-coding RNA-SChLAP1 overexpression on the prognosis of colorectal cancer(CRC).Methods A total of 156 CRC patients and 43 adjacent colorectal tissue of CRC were selected for qRT-PCR.The correlation between SChLAP1 expression and the clinicopathological characteristics,overall survival(OS),disease-free survival(DFS),and risk factors for OS and DFS in CRC patients were evaluated.Results The level of SChLAP1 in CRC was significantly higher than that in adjacent colorectal tissues,and the differences were statistically significant(P＜0.01).The high expression of SChLAP1 was related to the differentiation and stage of CRC,DFS and OS(P＜ 0.01).SChLAP1 expression was an independent risk factor for the OS and DFS of CRC patients.Conclusion SChLAP1 plays an important role in the progression of CRC.SChLAP1 may be used as an independent biomarker for the prognosis of CRC

Key words: LncRNA, SChLAP1, Colorectal cancer, Prognosis, Survival analysis

中图分类号:

R735.3

孙小艳, 张晓艳. LncRNA-SChLAP1在结直肠癌组织中高表达的预后评估意义[J]. 实用肿瘤学杂志, 2020, 34(5): 425-429.

SUN Xiaoyan, ZHANG Xiaoyan. Prognostic significance of lncRNA-SChLAP1 high-expression in colorectal cancer[J]. Journal of Practical Oncology, 2020, 34(5): 425-429.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2020.05.007

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2020/V34/I5/425

参考文献

1 Shibutani M,Maeda K,Nagahara H,et al.Prognostic significance of the preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer[J].Oncol Lett,2017,13(2):1000-1006.
2 Talseth-Palmer BA.The genetic basis of colonic adenomatous polyposis syndromes[J].Hered Cancer Clin Pract,2017,15:5.
3 Gu H,Li D,Zhu H,et al.The prognostic efficacy and improvements of the 7th edition Union for International Cancer Control tumor-node-metastasis classifications for Chinese patients with gastric cancer:results based on a retrospective three-decade population study[J].Tumour Biol,2017,39(3):1010428317694548.
4 Prensner JR,Iyer MK,Sahu A,et al.the long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex[J].Nat Genet,2013,45(11):1392-1398.
5 Mehra R,Shi Y,Udager AM,et al.A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer[J].Neoplasia,2014,16(12):1121-1127.
6 Hsu PK,Wu YC,Chou TY,et al.Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma[J].Ann Thorac Surg,2010,89(4):1024-1031.
7 王世卿,谭燕,孔繁勇,等.结直肠癌中原癌基因DEK与IMP3/Ezrin通路的相关性[J].辽东学院学报(自然科学版),2016,23(3):201-211.
8 Lin L,Zhang J,Wang Y,et al.Insulin like growth factor II mRNA binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma[J].Oncol Lett,2013,6(3):740-744.
9 Lin L,Chen L.Association between ezrin protein expression and the prognosis of colorectal adenocarcinoma[J].Mol Med Rep,2013,8(1):61-66.
10 李囡,阎晓雷,曹忠良,等.长链非编码RNA CAI2在神经胶质瘤中的表达及临床意义[J].中华实验外科杂志,2017,34(4):675-677.
11 Mouraviev V,Lee B,Patel V,et al.Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer[J].Prostate Cancer Prostatic Dis,2016,19(1):14-20.
12 Wilson BG,Roberts CW.SWI/SNF nucleosome remodellers and cancer[J].Nat Rev Cancer,2011,11(7):481-492.
13 Atala A.Re:the long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex[J].J Urol,2014,192(2):613.
14 Lee RS,Roberts CW.Linking the SWI/SNF complex to prostate cancer[J].Nat Genet,2013,45(11):1268-1269.
15 Mehra R,Udager AM,Ahearn TU,et al.Overexpression of the long non-coding rna schlap1 independently predicts lethal prostate cancer[J].Eur Urol,2016,70(4):549-552.
16 Link KA,Balasubramaniam S,Sharma A,et al.Targeting the BAF57 SWI/SNF subunit in prostate cancer:a novel platform to control androgen receptor activity[J].Cancer Res,2008,68(12):4551-4558.

[1]	牛明, 于歌. 促进乳腺癌增殖转移和肿瘤干细胞特征的研究[J]. 实用肿瘤学杂志, 2020, 34(6): 518-523.
[2]	左蕊, 金路, 刘丽, 刘小嘉, 赵鹏宇, 向小燕. miR-409-3p在肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2020, 34(6): 554-559.
[3]	刘恒昌, 魏然, 李春香, 刘正, 陈海鹏, 关旭, 赵志勋, 邹霜梅, 王锡山, 姜争. NOX4在结肠癌组织中的表达及与预后的关系[J]. 实用肿瘤学杂志, 2020, 34(5): 391-397.
[4]	董满库, 姜福全, 林海冠, 孙晓敏, 刘景欣, 胡刚, 杨建武. lncRNA BLACAT1靶向LEMD1促进结直肠癌细胞的增殖和转移[J]. 实用肿瘤学杂志, 2020, 34(5): 418-424.
[5]	尹松祥. Copine-8在胃癌组织中的表达与临床病理特征及预后的相关性[J]. 实用肿瘤学杂志, 2020, 34(5): 430-435.
[6]	赵仁成, 林子棠, 余卫军, 雷林, 刘峥, 徐英, 郭艳芳, 彭绩. 2017—2019年深圳市宝安区40~74岁常住居民五癌风险流行状况分析[J]. 实用肿瘤学杂志, 2020, 34(4): 315-320.
[7]	魏勇, 张玉海, 吕双双, 李月敏. 合并重症肌无力对胸腺瘤术后患者预后的影响[J]. 实用肿瘤学杂志, 2020, 34(4): 341-346.
[8]	李恒震, 张艳桥. 液体活检在结直肠癌诊断中的应用进展[J]. 实用肿瘤学杂志, 2020, 34(4): 357-361.
[9]	朱晓云, 张亚宁, 马碧萍. 1980—2018年上海市金山区结直肠癌死亡水平及其所致早死概率的趋势分析[J]. 实用肿瘤学杂志, 2020, 34(3): 198-202.
[10]	谢贤鑫, 韦军, 邱佳鑫, 王聪, 姜大庆. 乳腺癌新辅助化疗残余肿瘤组织病理信息与预后分析[J]. 实用肿瘤学杂志, 2020, 34(3): 225-231.
[11]	王棹, 冯越, 邢丽楠, 张云艳. PLR与恶性肿瘤同步放化疗预后的研究进展[J]. 实用肿瘤学杂志, 2020, 34(3): 271-275.
[12]	鲁雪梅, 李云涛, 安锦慧, 季国忠. 溶血磷脂酸在结直肠癌发生发展中的机制研究[J]. 实用肿瘤学杂志, 2020, 34(3): 276-281.
[13]	李斌, 冯保恒, 尹富霞, 苏伟. 建立结直肠癌移植瘤模型研究小鼠肠道中细菌感染情况及地西他滨联合顺铂化疗的作用机制[J]. 实用肿瘤学杂志, 2020, 34(2): 163-168.
[14]	苏文佳, 王树叶. 滤泡性淋巴瘤的预后分层和治疗进展[J]. 实用肿瘤学杂志, 2020, 34(2): 189-192.
[15]	曾理, 庄树彤, 丁世华, 陈冲, 焦璐, 孙大勇. 长链非编码RNA AFAP1-AS1通过PTEN/p-AKT信号通路调控结直肠癌细胞增殖的分子机制研究[J]. 实用肿瘤学杂志, 2020, 34(1): 11-16.

LncRNA-SChLAP1在结直肠癌组织中高表达的预后评估意义

Prognostic significance of lncRNA-SChLAP1 high-expression in colorectal cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价